Search

Un experto de MSK ofrece consejos sobre cómo hablar con familiares y amigos sobre un diagnóstico de cáncer relacionado con el VPH, algo que para algunas personas puede resultar especialmente difícil.

… Tuesday, May 3, 2022 Hablar sobre un diagnóstico de cáncer puede ser difícil. Hablar con amigos, familiares y otras personas sobre un diagnóstico de cáncer relacionado con el VPH puede resultar especialmente difícil para muchas personas. Victoria Lassen , trabajadora social clínica del Memorial Sloan

Meet Vanessa Rodriguez, who is an event production manager in the Office of Development, where she works to enhance donor relationships to help fund cancer research.

… Wednesday, September 15, 2021 A common thread of purpose-driven work is woven through Vanessa Rodriguez’s professional life. She has worked for various nonprofit organizations throughout her career and will celebrate her 10th anniversary at Memorial Sloan Kettering Cancer Center in October. “My husband

Memorial Sloan Kettering’s 42nd annual ceremony recognized graduates and award winners with a virtual ceremony.

… Thursday, May 20, 2021 Memorial Sloan Kettering’s 42nd annual Academic Convocation and Commencement ceremony, which took place on May 19, 2021, was held virtually for a second year due to the COVID-19 pandemic. Four members of MSK’s leadership team took to the stage in the Zuckerman Research Center,

At Memorial Sloan Kettering Cancer Center, we have now analyzed more than 50,000 samples in our prospective cohort with MSK-IMPACT™.

… Wednesday, February 24, 2021 At Memorial Sloan Kettering Cancer Center, we have now analyzed over 65,000 samples in our prospective cohort with MSK-IMPACT™ , our next-generation sequencing (NGS) platform, and are adding to that number every day. This is up 8000 from January this year, despite Covid-19

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Luis Alberto Diaz, Jr., MD, Head of the Division of Solid Tumor Oncology; Grayer Family Chair at MSK, has been elected to the 10th class of Giants of Cancer Care® for his contributions in translational science.

… Monday, May 9, 2022 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Luis Alberto Diaz, Jr., MD, Head of the Division of Solid Tumor Oncology; Grayer Family Chair at MSK, has been elected to the 10 th class of Giants of Cancer Care® for his contributions in translational science. The

Learn how immune cells in the lungs trigger invasive fungal cells to self-destruct. The discovery could produce therapies to prevent infection in cancer patients.

… Thursday, September 7, 2017 Summary Due to their weakened immune function, cancer patients who receive bone marrow transplants are at a high risk of infection from a common fungus called Aspergillus fumigatus . Researchers discovered that immune cells in the lungs of healthy people kill the fungal cells

Learn how Memorial Sloan Kettering Cancer Center kept caring for patients during the response to COVID-19, and how lessons learned during the pandemic are helping cancer care.

… Thursday, October 1, 2020 “It felt like watching a terrifying storm moving toward us in slow motion.” That is how Memorial Sloan Kettering lymphoma doctor Matthew Matasar describes watching the COVID-19 pandemic unfold. MSK doctors, researchers, and staff never wavered in their commitment to continue

Recent research from Memorial Sloan Kettering shows that dual-energy contrast-enhanced digital mammography (CEDM) is as sensitive in detecting breast cancer as contrast-enhanced breast MRI when both were compared with standard mammograms.

… Friday, December 8, 2017 Donna D’Alessio, MD Donna D’Alessio, MD Recent research from Memorial Sloan Kettering shows that dual-energy contrast-enhanced digital mammography (CEDM) is as sensitive in detecting breast cancer as contrast-enhanced breast MRI when both were compared with standard mammograms

Memorial Sloan Kettering’s new research complex contains more than 100 laboratories, nearly doubling the space we dedicate to research to better understand and treat cancer.

… Wednesday, October 17, 2012 Summary Memorial Sloan Kettering’s new research complex contains more than 100 laboratories, nearly doubling the space we dedicate to research to better understand and treat cancer. Construction on the Mortimer B. Zuckerman Research Center – named in recognition of the $100

The US Food and Drug Administration (FDA) has approved the drug naxitamab (Danyelza) for the treatment of patients with high-risk neuroblastoma. The drug, also known as humanized 3F8, was developed by researchers at MSK Kids, the pediatric cancer program at Memorial Sloan Kettering.

… Tuesday, January 5, 2021 The US Food and Drug Administration (FDA) has approved the drug naxitamab (Danyelza) for the treatment of patients with high-risk neuroblastoma.  The drug , also known as humanized 3F8, was developed by researchers at MSK Kids, the pediatric cancer program at Memorial Sloan Kettering